Oncolytics Biotech, Inc. (ONCY)
0.4078
-0.03
(-7.19%)
USD |
NASDAQ |
Nov 09, 16:00
0.41
0.00 (0.00%)
After-Hours: 19:29
Oncolytics Biotech Total Return Level : 0.4394 for Nov. 6, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 06, 2026 | 0.4394 |
| November 05, 2026 | 0.4488 |
| November 04, 2026 | 0.4248 |
| November 03, 2026 | 0.39 |
| November 02, 2026 | 0.40 |
| October 30, 2026 | 0.4254 |
| October 29, 2026 | 0.4277 |
| October 28, 2026 | 0.4416 |
| October 27, 2026 | 0.4623 |
| October 26, 2026 | 0.4732 |
| October 23, 2026 | 0.5023 |
| October 22, 2026 | 0.5002 |
| October 21, 2026 | 0.5114 |
| October 20, 2026 | 0.4986 |
| October 19, 2026 | 0.4963 |
| October 16, 2026 | 0.4981 |
| October 15, 2026 | 0.5476 |
| October 14, 2026 | 0.5382 |
| October 13, 2026 | 0.49 |
| October 12, 2026 | 0.4733 |
| October 09, 2026 | 0.557 |
| October 08, 2026 | 0.5444 |
| October 07, 2026 | 0.5958 |
| October 06, 2026 | 0.598 |
| October 05, 2026 | 0.5969 |
| Date | Value |
|---|---|
| October 02, 2026 | 0.631 |
| October 01, 2026 | 0.6412 |
| September 30, 2026 | 0.6682 |
| September 29, 2026 | 0.6745 |
| September 28, 2026 | 0.663 |
| September 25, 2026 | 0.6833 |
| September 24, 2026 | 0.6792 |
| September 23, 2026 | 0.6765 |
| September 22, 2026 | 0.7133 |
| September 21, 2026 | 0.7663 |
| September 18, 2026 | 0.77 |
| September 17, 2026 | 0.77 |
| September 16, 2026 | 0.7688 |
| September 15, 2026 | 0.78 |
| September 14, 2026 | 0.8127 |
| September 11, 2026 | 0.7455 |
| September 10, 2026 | 0.772 |
| September 09, 2026 | 0.795 |
| September 08, 2026 | 0.805 |
| September 04, 2026 | 0.8432 |
| September 03, 2026 | 0.8565 |
| September 02, 2026 | 0.88 |
| September 01, 2026 | 0.84 |
| August 31, 2026 | 0.8382 |
| August 28, 2026 | 0.8566 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Revolution Medicines, Inc. | 192.28 |
| Arrowhead Pharmaceuticals, Inc. | 58.16 |
| Sangamo Therapeutics, Inc. | 0.114 |
| Sarepta Therapeutics, Inc. | 17.82 |
| Anixa Biosciences, Inc. | 3.175 |